Collaboration Announced to Develop Hadassah Drug to Treat “Untreatable” NASH Liver Disease
Hadasit, the Hadassah Medical Organization’s technology transfer company, has signed an agreement with BioLineRx Ltd. to develop a drug to treat non-alcoholic steatohepatitis (NASH), based on the pre-clinical work of…
